Sofia Fund has invested about $10 million in 50 female-led companies and diverse founding teams since its inception in 1998--about half of which have exited. Sofia is now investing out of its second fund, which raised $5.5 million, and seeks out companies in IT, business products and services, and health and wellness. It receives 100 to 150 requests for funding each year. While Sofia is structured as a venture fund (not an angel network), its own investors are individuals rather than institutions. The fund's companies include Oculogica, which makes a technology for diagnosing traumatic brain injuries, and Cognition Therapeutics, which is pursuing treatment for Alzheimer's. Sofia was also an early investor in Tactile Medical, which went public in 2016.